NASDAQ:MDAS - MedAssets Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$31.35
Today's Range$31.35 - $31.35
52-Week Range$17.00 - $31.35
VolumeN/A
Average Volume1.79 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MedAssets, Inc. (MedAssets) provides technology-enabled products and services to healthcare organizations, including hospitals, health systems, non-acute healthcare providers, payers, other service providers and product manufacturers. The Company operates its business through two business segments: Spend and Clinical Resource Management (SCM) and Revenue Cycle Management (RCM). The SCM segment delivers market insight, performance improvement advisory and cost management capabilities to healthcare providers. The RCM segment provides revenue cycle management solutions to healthcare providers, primarily hospitals and health systems. The Company's technology-enabled solutions are delivered through the Company-hosted software or software as a service (SaaS) or Web-based applications. Its Web-based applications employ cloud computing by using the Internet to deploy the Company's solutions across decentralized health care organizations, providing standardization and compliance.

Receive MDAS News and Ratings via Email

Sign-up to receive the latest news and ratings for MDAS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryHealth Care Technology
SectorN/A
Current SymbolNASDAQ:MDAS
CUSIP58404510
Phone+1-678-3232500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

MedAssets (NASDAQ:MDAS) Frequently Asked Questions

What is MedAssets' stock symbol?

MedAssets trades on the NASDAQ under the ticker symbol "MDAS."

How were MedAssets' earnings last quarter?

MedAssets, Inc. (NASDAQ:MDAS) released its earnings results on Wednesday, July, 29th. The technology company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.04. The technology company earned $190.40 million during the quarter, compared to analyst estimates of $187.45 million. The company's quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.30 EPS. View MedAssets' Earnings History.

Has MedAssets been receiving favorable news coverage?

Media headlines about MDAS stock have trended very positive this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. MedAssets earned a coverage optimism score of 3.2 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

How do I buy shares of MedAssets?

Shares of MDAS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MedAssets' official website?

The official website for MedAssets is http://www.medassets.com.

How can I contact MedAssets?

MedAssets' mailing address is 100 N Point Ctr E Ste 200, ALPHARETTA, GA 30022-8261, United States. The technology company can be reached via phone at +1-678-3232500.


MarketBeat Community Rating for MedAssets (NASDAQ MDAS)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  263 (Vote Outperform)
Underperform Votes:  319 (Vote Underperform)
Total Votes:  582
MarketBeat's community ratings are surveys of what our community members think about MedAssets and other stocks. Vote "Outperform" if you believe MDAS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDAS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2019 by MarketBeat.com Staff

Featured Article: Liquidity

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel